Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Douglas Hancox


Recent stories

  • Mixed reviews about The Pharmaceutical JournalSubscription

    22 FEB 2017

    I have read The Pharmaceutical Journal since the days of my pharmacy apprenticeship. I have always valued my receipt of it, have always found items of interest and value in it, and I continue to do so to this day. In addition, even though I go online to the website three or four times a week, I still find fresh items of interest or value when I receive the print edition. Given the variety of roles individual pharmacists undertake — including those in areas of

  • If you want to influence pharmacy’s future, vote in the RPS electionsSubscription

    22 APR 2016

    Our profession continues to face many challenges, not only those raised by the Department of Health consultation and the Carter review but also those such as the development of five-year integrated MPharm degree and improvements to training and experience in the preregistration year. Strong national pharmacy boards are needed to address these challenges and to lead the profession and the Royal Pharmaceutical Society (RPS) forward. Voting in the RPS national pharmacy board elections wil

  • Issues with preregistration training need resolving nowSubscription

    8 OCT 2015

    Since its introduction there have been concerns around the General Pharmaceutical Council’s (GPhC) registration assessment, particularly in respect of its negative impact on preregistration trainees’ during the latter part of their training year. The recent letters and articles in The Pharmaceutical Journal echo the concerns raised in The Journal in 2011 and in discussions on the Royal Pharmaceutical Society’s general group virtual network. It is good news that the GP

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.